Correlation Between Lyxor 1 and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lyxor 1 and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyxor 1 and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyxor 1 and Astellas Pharma, you can compare the effects of market volatilities on Lyxor 1 and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyxor 1 with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyxor 1 and Astellas Pharma.

Diversification Opportunities for Lyxor 1 and Astellas Pharma

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lyxor and Astellas is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Lyxor 1 and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Lyxor 1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyxor 1 are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Lyxor 1 i.e., Lyxor 1 and Astellas Pharma go up and down completely randomly.

Pair Corralation between Lyxor 1 and Astellas Pharma

Assuming the 90 days trading horizon Lyxor 1 is expected to generate 0.47 times more return on investment than Astellas Pharma. However, Lyxor 1 is 2.11 times less risky than Astellas Pharma. It trades about 0.06 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.02 per unit of risk. If you would invest  2,180  in Lyxor 1 on September 1, 2024 and sell it today you would earn a total of  292.00  from holding Lyxor 1 or generate 13.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.64%
ValuesDaily Returns

Lyxor 1   vs.  Astellas Pharma

 Performance 
       Timeline  
Lyxor 1 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lyxor 1 are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Lyxor 1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Lyxor 1 and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lyxor 1 and Astellas Pharma

The main advantage of trading using opposite Lyxor 1 and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyxor 1 position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind Lyxor 1 and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas